Skip to main content

Advertisement

Table 3 Determinants of the eGFR - Adjusted mixed effect linear regression

From: Impact of Arteriovenous fistula creation on estimated glomerular filtration rate decline in Predialysis patients

Covariatesβ Estimate (95% CI)P-value
Follow-up time (months)−0.63 (− 0.81, − 0.46)<  0.001
Period after AVF (ref. before)0.94 (0.61, 1.26)<  0.001
Follow-up time * period after AVF (ref. before)0.19 (0.16, 0.22)< 0.001
Female−0.69 (−1.48, 0.11)0.09
Age (per 5-year increase)0.03 (−0.13, 0.18)0.73
Follow-up time * Age0.02 (0.01–0.04)0.001
Black race (ref. White/other)2.73 (0.89, 4.57)0.004
Follow-up time * Black race−0.20 (−0.35, − 0.05)0.01
RAAS blockade use1.82 (0.89, 2.75)< 0.001
Diabetes0.87 (0.03, 1.71)0.04
  1. AVF arteriovenous fistula, RAAS renin angiotensin aldosterone system